ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,604, issued on April 21, was assigned to Regents of the University of Minnesota (Minneapolis).
"Therapeutic compounds and methods" was invented by Daniel Attilio Vallera (Richfield, Minn.) and Jeffrey S. Miller (Little Canada, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes engineered compounds that engage NK cells and methods of using the compounds. Generally, the compound includes an NK engaging domain, a targeting domain that selectively binds to a target cell, and an NK activating domain operably linking the NK engaging domain and the targeting domain."
The patent was filed on Aug. 6, 2021, under Application No. ...